Alnylam Pharmaceuticals
ALNY
#446
Rank
โ‚ฌ44.72 B
Marketcap
338,51ย โ‚ฌ
Share price
-3.65%
Change (1 day)
44.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company